Contraceptives and the risk of HIV infection

30 Jun 2019 - 10:30

The results of the ECHO study (a randomised, open-label trial), presented at the AIDS Conference in Durban, were recently published online in the Lancet by the Echo Trial consortium and provides reassuring evidence that certain hormonal methods of contraception do not predispose users to HIV acquisition.

Previous observational and laboratory studies had suggested that intramuscular depot medroxyprogesterone acetate in particular, might increase the risk of HIV infection.

Read the full open access article in The Lancet.